Anima Biotech is pioneering the development of small molecule mRNA drugs. Their proprietary platform, mRNA Lightning, leverages AI to discover and optimize molecules that modulate mRNA biology in a wide range of diseases. Anima's pipeline of mRNA biology modulators are in immunology, oncology, and neuroscience. Included are a preclinical candidate for lung fibrosis, lead compounds for solid tumors entering preclinical stages, and programs against lymphoma, neuroblastoma, Alzheimer's disease, and pain. Additionally, Anima Biotech has established strategic collaborations with major pharmaceutical companies like Lilly, Takeda, and AbbVie, expanding their reach and accelerating the development of their pipeline.

Anima Biotech

Founded: 2015
Location: Bernardsville, New Jersey
Employee range: 51 - 100
Clinical stage: RD/Clin0
Therapy area: Lung fibrosis
Drug types: LNG, ONC, NEU, GEN, PN
Lead product: Undisclosed
Funding: not disclosed

Drug notes:

About:

Jobs: